-
Medical Marijuana – a Role for Clinical Pharmacists?
Medical Marijuana may provide a role for for trained clinical pharmacists which could evolve remarkably and prove rewarding in multiple ways. Pharmacists are not only trained to safely supply sensitive drugs, but also to educate patients in their safe use. Primarily it could provide a solution for many patients suffering from chronic neurological pain. These patient types seem to be…
-
Australia a new growth market for cannabis
Australia has been flagged as a growth market for medical cannabis. A company that has listed on the Australian Securities Exchange hopes to capitalise on a growing worldwide demand for medicinal cannabis. Clinical trials are currently being organised in NSW and announcements are expected around mid-2015. According to Chicago cannabis industry attorney Davis Legal, PLLC,…
-
ASMI Media Releases 1.New research confirms benefits of chondroitin for osteoarthritis 2. ASMI welcomes complementary meds review
New research confirms benefits of chondroitin for osteoarthritis 27 February 2015 – The Australian Self Medication Industry (ASMI) today welcomed new research that confirmed the benefits of chondroitin sulphate for osteoarthritis. A Cochrane Review of 9,110 people across 43 randomised controlled studies revealed that chondroitin sulphate (alone or in combination with glucosamine) was better than…
-
Medicines That Matter – Drug Schedules Administered by Pharmacists
It’s taken a long time for pharmacy proprietors and their leadership body to take a good look and this sector of medicines and actually do something with it. But at least it is being reviewed and that has to be a plus. Another sector, with only a handful of scheduled items within it is the…
-
ASMI Media Releases – ASMI Elections, ANZTPA Comment, Diamond Awards, Conference Highlights
Bayer’s Mark Sargent re-elected as ASMI President 20 November 2014 – The Australian Self Medication Industry (ASMI) today announced the reelection of Mark Sargent, General Manager Consumer Care Australia & New Zealand, Bayer Australia Limited, as its President. Speaking on his re-election, Mark Sargent said: “I am delighted to continue for another term as President…
-
ASMI Media Releases 1. ASMI Conference – Self Care 2. ASMI Conference-Transforming Pharmacy
ASMI 2014 Conference: Self care emerging as central to sustainable health policy 28 October 2014 – Interest in self care is growing worldwide particularly in developed economies such as the UK, Australia and the US. In the UK, momentum has been slowly building since 2000 when the National Health Service Blueprint (NHS Plan) was announced…
-
ASMI Media Releases – 1. Switching Lag 2. New Complementary Meds Research 3. Govt. to Cut Red Tape
Australia behind the rest of the world on switch 17 October 2014 – The Australian Self Medication Industry (ASMI) says New Zealand is leading the way in improving consumer access to medicines. A number of medicines such as trimethoprim for urinary tract infection; triptans for migraine; oseltamivir for flu and flu vaccines are available in…
-
ASMI Media Releases – 1. S3 Advertising Reform 2. TGA Review of OTC NSAIDs
ASMI says S3 advertising reform long overdue 13 October 2014 – The Australian Self Medication Industry (ASMI) said that S3 advertising restrictions constrain the ability of sponsors to make consumers aware of medicines that are available without a prescription, and regulatory reform is long overdue. In a presentation at the annual Pharmacy Australia Conference (PAC),…
-
ASMI Media Release – Consumer behaviour expert says Australian consumers want more prescription products as OTC
24 September 2014 – Australia’s system of scheduling medicines means that Australian consumers cannot access several non-prescription medicines over-the-counter (OTC) that are available without a prescription in many other countries, says consumer behaviour expert Professor Scott Koslow. Professor Koslow will present the results of new research on consumers’ current and future potential behaviour in relation…